Publications & Presentations

Sections:   Books, Papers, Abstracts & Letters,  Videos & Multimedia, Invited Lectures,  Google Scholar:Andrew. Andrew ORCID ID Google Scholar:Martha  Google Scholar:Oliver.

Books

Kaplan A, Opheim KE, Jack R, Toivola B, Lyon AW. 1995. Clinical Chemistry: Interpretation and Techniques. 4th Edition. Philadelphia, Lea and Febiger, 475.

Lyon AW. 1988. Characterization of the inhibition of hepatic protein synthesis during acute ethionine intoxication of the rat. Doctoral Thesis. Queen's University, Kingston, Ontario

Book - Chapters

Wu F, Lyon AW, Lyon ME. Chapter 10.3 The importance of selecting an appropriate method for measuring methotrexate concentration after glucarpidase rescue: immunoassay or LC-MS/MS? in Toxicology Cases for the Clinical and Forensic Laboratory, H. Ketha and U.Garg ed. Elsevier, 2020. pp 161-3.

Lyon AW, Zherebitskiy VA, Wu F. Chapter 20.1 Evaluation of toxicity following ammonia exposure: A case report. in Toxicology Cases for the Clinical and Forensic Laboratory, H. Ketha and U.Garg ed. Elsevier, 2020. pp 397-9.

Jane Alcorn, Stephanie Vuong, Fang Wu, Blair Seifert and Andrew Lyon. Pediatric Dosing Considerations for Medical Cannabis [Online First], in Recent Advances in Cannabinoid Research, Ed. Dr. Willard James Costain and Dr. Robert Brad Laprairie. March 2019 IntechOpen, DOI: 10.5772/intechopen.85399.

Lyon AW, Lyon ME.  Flame Atomic Emission Spectrometry and Atomic Absorption Spectrometry.  Encyclopedia of Medical Devices and Instrumentation 2nd Ed.  Editor J.G. Webster. J.W. Wiley & Sons, Inc. Hoboken, NJ. 2006  pp. 315-322.

Editorial Activities:

Clinical Biochemistry: Editorial Board (present) and Associate Editor (2007-2012).

Journal of Laboratory and Precision Medicine Editorial Board ( 2018-2020) 

BMC Pregnancy and Childbirth 2013; 13 Suppl 1 Preterm Birth and Healthy Outcome Team (PreHOT) Research Supplement.

Eds: A.W.Lyon, B.F. Mitchell, O. McCreary.

(websites listed below)

Papers

1. Kavsak PA, Clark L, Arnoldo S, Lou A et al. Imprecision of high-sensitivity cardiac troponin assays at the female 99th-percentile. Clin Biochem 2024; 125. https://doi.org/10.1016/j.clinbiochem.2024.110731.

2. Kavsak PA, Clark L, Arnoldo S, Lou A, Shea JL, Eintracht S, Lyon AW, Bhayana V, Thorlacius L, Raizman JE, Tsui AKY, Djiana R, Chen M, Huang Y, Booth RA, McCudden C, Lavoie J, Beriault DR, Blank DW, Fung AWS, Hoffman B, Taher J, St-Cyr J, Yip PM, Belley-Cote EP, Abramson BL, Borgundvaag B, Friedman SM, Mak S, McLaren J, Steinhart B, Udell JA, Wijeysundera HC, Atkinson P, Campbell SG, Chandra K, Cox JL, Mulvagh S, Quraishi AU, Chen-Tournoux A, Clark G, Segal E, Suskin N, Johri AM, Sivilotti MLA, Garuba H, Thiruganasambandamoorthy V, Robinson S, Scheuermeyer F, Humphries KH, Than M, Pickering JW, Worster A, Mills NL, Devereaux PJ, Jaffe AS. Analytic result variation for high-sensitivity cardiac troponin: Interpretation and consequences. Can J Cardiol. 2023; 39: 947-51. 

3. MacDonald AM, Gabos S, Braakman S, Cheperdak L, Lee B, Lyon ME, Lyon AW et al. Maternal and child biomonitoring strategies and levels of exposure in western Canada during the past seventeen years: The Alberta Biomonitoring Program: 2005-2021. Int J Hyg and Envir Health. 2022; 244.

4. Cembrowski GS, Lyon AW, McCudden C, Qiu Y, Xu Q, Mei J, Tran DV, Sadrzadeh SMH, Cervinski MA. Transformation of Sequential Hospital and Outpatient Laboratory Data into Between-Day Reference Change Values. Clin Chem 2022; 68: 595-603. 

5. Stritzke AI, Ismail R, Rose S, Lyon A, Fenton T. Cord-blood derived chemistry reference values in preterm infants for sodium, chloride, potassium, glucose, and creatinine. Am J Perinatol 2022; Feb 7.

6. Lyon ME, Lyon AW. N-Acetylcysteine Interference with a Glucose Dehydrogenase Linked Glucose meter.  J Sci Diabet Technol -2021; 16: 1114-9. 

7. Lyon ME, Bajkov A, Haugrud D, Kyle BD, Wu F, Lyon AW. COVID-19 Pandemic Planning: Simulation models to predict biochemistry test capacity for patient surges. J Appl Lab Med. 2021, 6(2): 451-62.  DOI.org/10.1093/jalm/jfaa231

8. Stephenson N, Hornaday K, Doktorchik C, Lyon AW, Tough SC, Slater D.  Quality assessment of RNA in long-term storage: The All Our Families biorepository. PLOS One. 2020; Dec 1;15(12):e0242404.   DOI: 10.1371/journal.pone.0242404.

9. Inman M, Lyon AW, Lyon OAS, Lyon ME. Estimated Risk for Insulin Dose Error Among Hospital Patients Due to Glucose Meter Hematocrit Bias in 2020. Arch Pathol Lab Med. 2020;144:1204-8.

10. Zhao Y, Izadnegahdar M, Lee M, Kavsak P, Singer J, Scheuermeyer F, Udell J, Robinson S, Norris C, Lyon AW, Pilote L, Cox J, Hassan A, Rychtera A, Johnson D; Mills NL, Christenson J, Humphries K. High-Sensitivity Cardiac Troponin - Optimizing the Diagnosis of Acute Myocardial Infarction/Injury in Women (CODE-MI): Rationale and Design for a Multi-centre Stepped-Wedge Cluster Randomized Trial American Heart Journal. 2020; 229: 18-28.

11. Lyon AW, Delayen K, Reddekopp R. “No lab tests” when you are born in The Twilight Zone: A Clinical Informatics Case Report J Appl Lab Med. 2020; 5(6): 1395-1400.

12. Andrews AR, Yu D, Lyon AW. Diagnostic challenges with acyclovir crystalluria: a case study. eJIFCC. 2020; 31(2): 157-63.

13. Lyon AW, Lyon ME. Evaluation of precision and bias specifications required to acheive the 2018 FDA guidedance criteria for glucose meter performance using simulation models J Sci Diabet Technol. 2020; 14(3):513-8.

14. Inman M, Parker K, Strueby L, Lyon AW, Lyon ME. A simulation study to assess the effect of analytic error on neonatal glucose measurments using the Canadian Pediatric Society position statement action thresholds. J Diabet Sci Technol. 2020; 14(3):519-25.

15. Huntsman RJ, Tang-Wai R, Alcorn J, Vuong S, Acton B, Corley S, Laprairie RB, Lyon AW, Meier S, Mousseau DD, Newmeyer D, Prosser-Loose E, Seifert B, Tellez-Zenteno JF, Huh L, Leung E, Major P. Dosage Related Efficacy and Tolerability of Cannabidiol in Children with Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study Front Neurol 03 July 2019.

16. Lyon ME, Lyon OAS, Tran NK, Dubois JA, Lyon AW. An insulin-dose error assessment grid: A new tool to evaluate glucose meter performance. Clin Biochem 2019; 70:30-3.

17. Leis B, Frost A, Bryce R, Lyon AW, Coverett K. Altering standard admission order sets to promote clinical laboratory stewardship: a cohort quality improvement study BMJ Qual Saf. 2019; 28: 846-52.

18. Al-Wassia H, Lyon AW, Rose SM, Sauve RS, Fenton TR. Hypophosphatemia is Prevalent among Preterm Infants Less than 1,500 Grams. Am J Perinatol. 2019; 36: 1412-9.

19. Poonja Z,Uppal J, Netheron SJ, Bryce R, Lyon AW, and Cload B. Evaluation of emergency department ultrasound machines for presence of occult blood. Can J Emerg Med 2019; 21:395-8.

20. Reithmeier D, Tang-Wai R, Seifert B, Lyon A, Alcorn J, Acton B, Corley S, Prosser-Loose E, Mousseau D, Lim H, Tellez-Zenteno J, Huh L, Leung E, Carmant L, Huntsman RJ. The protocol for the Cannabidiol in Children with Refractory Epileptic Encephalopathy (CARE-E) Study: A phase 1 dosage escalation study. BMC Pediatrics, 2018; 18:221.

21. Gibson M, Waterhouse C, Lyon AW, Fenton TR. Immunoglobulin A and protein content of low-fat human milk prepared for the treatment of chylothorax. Nutr Clin Pract, 2018; 33:667-70

22. Lyon AW, Lyon ME. Precision medicine and cardiac troponin biomarkers: new practice recommendations advance diagnostic precision. J Lab Precis Med, 2018; 3:44

23. Huntsman RJ, Tang-Wai R, Acton B, Alcorn J, Lyon AW, Mousseau DD, Seifert B, Lapairie R, Prosser-Loose E, Hanus LO. Cannabis for the treatment of paediatric epilepsy? An update for Canadian paediatricians. Paediatr Child Health 2018; 23:368-73.

24. Lano IM, Lyon AW, Wang L, Ruskin R, Lyon ME. Comparative evaluation of neonatal bilirubin using Radiometer whole blood co-oximetry and plasma bilirubin methods from Roche Diagnostics and Ortho Clinical Diagnostics. Clin Biochem 2018; 53:88-92

25. Lyon ME, Lyon AW. Do point of care cardiac troponin assays perform sufficiently well to achieve clinical guidelines to rule-in or to rule-out acute myocardial infarction? Clin Lab Int 2017; 41(Dec):14-7.

26. Lyon AW and Lyon ME. The dual personality of hemoglobin A1c: Precision medicine biomarker and population mortality predictor for both adult and geriatric patients. J Lab Precis Med 2017;2:21.

27. Lyon ME, Sinha R, Lyon OAS, Lyon AW.Application of a simulation model to estimate treatment error and clinical risk derived from point of care INR device analytic performance. J Appl Lab Med 2017; 2:25-32.

28. Lyon AW, La Rocque H, Corriveau S, Saunders R. Instrument error codes and diagnostic serendipity: A case report. J Appl Lab Med 2017; 1:740-4.

29. Dubois JA, Slingerland RJ, Fokkert M, Roman A, Tran NK, Clarke W, Sartori DA, Palmieri TL, Malic A, Lyon ME, Lyon AW. Bedside glucose monitoring—is it safe? A new, regulatory-compliant risk assessment evaluation protocol in critically ill patient care settings. Crit Care Med 2017; 45:567-74.

30. Lyon AW, Kavsak PA, Lyon OAS, Worster A, Lyon ME. Simulation models of misclassification error for single thresholds of high-sensitivity cardiac troponin I due to bias and imprecision. Clin Chem 2017; 63: 585-92.

31. Heng J, Pennell CE, McDonald SW, Vinturache AE, Xu J, Lee MWF, Briollais L, Lyon AW, Slater DM, Bocking AD, de Koning L, Olson DM, Dolan SM, Tough SC, Lye SJ. (2016) Maternal Whole Blood Gene Expression at 18 and 28 weeks of Gestation Associated with Spontaneous Preterm Birth in Asymptomatic Women. PLoS ONE 11(6): e0155191. doi: 10.1371/journal.pone.0155191 .

32. Lyon ME, Lyon AW. Evolutionary economics of Point of Care Testing: Value at the bedside, links to outcome, and Theranos. Point of Care 2015; 14(4):108-9.

33. Lyon ME, Baerg K, Olson T, Agnew BL, Smith Fehr J, Lyon AW. The clinical impact of implementing the Roche® bilirubin total Gen.3 method on neonate phototherapy. Clin Biochem 2015; 48: 1171-1173.

34. Metcalfe A, Lix LM, Johnson J-A, Currie G, Lyon AW, Bernier F, Tough SC. Validation of an obstetric comorbidity index in an external population. BJOG 2015; 122(13):1748-55.

35. Hicks M, Tough SC, Johnston D, Siever J, Clarke M, Sauve R, Brant R, Lyon AW. T-ACE and predictors of self-reported alcohol use during pregnancy in a large, population-based urban cohort Int J Alcohol Drug Res 2014; 3(1): 51-61.

36. Dreniak MA, Lyon AW, Fenton TR. Evaluation of fat separation and removal methods to prepare low-fat breast milk for fat-intolerant neonates with chylothorax. Nutri in Clin Pract. 2013; 28(5): 599-602.

37. Metcalfe A, Lyon AW, Johnson J, Bernier F, Currie G, Lix LM, Tough SC. Improving completeness of ascertainment and quality of information for pregnancies through linkage of administrative and clinical data records. Ann Epidemiol 2013; 23(7):444-7.

38. Metcalfe A, Lix LM, Johnson J, Bernier F, Currie G, Lyon AW, Tough SC. Assessing the impact of the SOGC recommendations to increase access to prenatal screening on overall health resource utilization in pregnancy. J Obstet Gynaecol Can 2013; 35(5): 444-453.

39. Metcalfe A, Currie G, Johnson J, Bernier F, Lix LM, Lyon AW, Tough SC. Impact of observed versus hypothesized service utilization on the incremental cost of first trimester screening and prenatal diagnosis in a Canadian province. Prenat Diagn 2013; 33(5): 429-35..

40. McDonald SW, Lyon AW, Benzies K, McNeil D, Lye S, Dolan S, Pennel C, Bocking A.,Tough SC. The All Our Babies Pregnancy Cohort: Design, Methods, and Participant Characteristics. BMC Preg. Child. 2013; 13: suppl. 1.

41. Pratt LM, Liu Y, Ugarte-Torres A, Hoegh-Petersen M, Podgorny PJ, Lyon AW, Williamson TS, Khan FM, Chaudhry MA, Daly A, Stewart DA, Russell JA, Grigg A, Ritchie D, Storek J. IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD. Bone Marrow Transplant. 2012; 48(5): 722-8.

42. Lyon AW, Chin AC, Slotsve GA, Lyon ME. Simulation of repetitive diagnostic blood loss and onset of iatrogenic anemia in critical care patients with a mathematical model. Comput Biol Med 2013; 43: 84-90.

43. Sarah L. Czerwinski SL, Lyon AW, Skorobohach B, Léguillette R. Pharmacokinetic analysis of topical tobramycin in equine tears by automated immunoassay. BMC Vet Res. 2012, 8:141.

44. Lyon ME, Lyon AW. Analysis of an Electrochemical Blood Glucose Monitoring System with Hematocrit Compensation: Improved Accuracy by Design. J Diab Sci Technol 2012; 6:656–658.

45. Khan FM, Ueno-Yamanouchi A, Serushago B, Bowen T, Lyon AW, Lu C, Storek J. Basophil activation test compared to skin prick test and fluorescence enzyme immunoassay for aeroallergen-specific Immunoglobulin-E. Allergy Asthma Clin Immunol. 2012 Jan 20;8(1):1

46. Fenton TR, Lyon AW. Milk and Acid-Base Balance: Proposed Hypothesis versus Scientific Evidence. J Am Coll Nutr 2011; 30(5): 471S-475S.

47. Straseski JA, Lyon ME, Clarke W, Dubois JA, Phelan LA, Lyon AW. Investigating Interferences of a Whole-Blood Point-of-Care Creatinine Analyzer: Comparison to Plasma Enzymatic and Definitive Creatinine Methods in an Acute-Care Setting. Clin Chem.2011; 57: 1566-73. Podcast Interview Link and Interview Transcript.

48. Fenton TR, Lyon AW, Rose MS. Calcium, phosphate, magnesium and alkaline phosphatase gestational age-specific reference intervals for preterm infants. BMC Pediatrics 2011, 11:76.

49. Pollak PT, Verjee Z, Lyon AW. Risperidone-induced QT prolongation following overdose correlates with serum drug concentration and  resolves rapidly with no evidence of altered pharmacokinetics. J Clin Pharmacol 2011; 51: 1112-5.

50. Fenton TR, Tough SC, Lyon AW, Eliasziw M, and Hanley DA. Causal assessment of dietary acid load and bone disease: A systematic review and meta-analysis applying Hill's epidemiologic criteria for causality. Nutrition Journal 2011, 10:41

51. Lyon ME, Lyon AW. Patient acuity exacerbates discrepancy between whole blood and plasma
    methods through bias and variance in molality to molarity conversion: “Mind the gap!” - Clin Biochem 2011; 44:412-417.

52. Lyon ME, Lyon AW. Analysis of the Performance of the CONTOUR-TS Blood Glucose Monitoring System:  When regulatory performance criteria are met, should we have confidence to use a medical device with all patients? Journal of Diabetes Science and Technology 2011; 5(1):1788-1790.

53. Gracie SK, Lyon AW, Kehler HL, Pennell CE, Dolan SM, McNeil DA, Siever JE, McDonald SW, Bocking AD, Lye SJ, Hegadoren KM, Olson DM, Tough SC. All Our Babies Study: Community-based cohorts to assess the association of pregnancy experience and birth outcomes, including preterm birth, in Alberta, Canada. BMC Pregnancy and Childbirth 2010, 10:87.

54. ME Lyon, JA DuBois,GH Fick, AW Lyon. Estimates of analytical error in consumer and hospital glucose meters contributed by hematocrit, maltose and ascorbate. J. Diabet Sci Technol, 2010; 4(6):1479-1494.

55. Fenton TR, Eliasziw M, Lyon AW,Tough SC, Brown JP and Hanley DA. Low urine pH and acid excretion do not predict bone fractures or the loss of bone mineral density: a prospective cohort study. BMC Musculoskeletal Disorders 2010, 11:88.

56. Csorba TR, Lyon AW, Hollenberg MD. Autoimmunity and the pathogenesis of type 1 diabetes. Crit Rev Clin Lab Sci. 2010; 47: 51-71.

57. M. E. Lyon, D. Gray, L.B. Baskin, J.A. Dubois, AW. Lyon. A mathematical model to assess the influence of hematocrit on point of care glucose meter performance. Clin Biochem. 2010; 43: 905-9.

58. Lyon AW, James J, Lemaire C, Culleton B. Comparison of the multiple-aliquot and batch methods of monitoring peritoneal dialysis adequacy in patients. Perit Dial Int. 2010; 30: 91-4.

59. Fenton TR, Lyon AW, Eliasziw M, Tough SC, Hanley DA. Phosphate decreases urine calcium and increases calcium balance: A meta-analysis of the osteoporosis acid-ash diet hypothesis. Nutrition J: 2009; 8:41.

60. Fenton TR, Eliasziw M, Lyon AW, Tough SC, Brown JP, Hanley DA. Low 5-year stability of within-patient ion excretion and urine pH in fasting-morning-urine specimens. Nutr Res. 2009; 29(5): 320-6.

61. Higgins T, Saw W, Sikaris K, Cembrowski GC, Lyon AW, Khajuria A, Tran D. Seasonal variation in hemoglobin A1c: Is it the same in both hemispheres? J. Diabetes Sci Technol 2009; 3(4):668-671.

62. Fenton, TR, Lyon AW, Eliasziw M, Tough SC, Hanley DA. A meta-analysis of the effect of the acid-ash hypothesis of osteoporosis on calcium balance. J Bone Min Res. 2009; 24:1835-40.

63. Lyon AW, Higgins TN, Wesenberg JC, Tran DV. Variation in the frequency of HbA1c testing: Population-studies to assess compliance with clinical practice guidelines and use of HbA1c to screen for diabetes. J Diabetes Sci Technol 2009; 3: 411-417.

64. Tran DV, Lyon AW, Higgins TN, Wesenberg JC, Vandergouwe L, Cembrowski GS. Use of serial patient differences of immunoassay and HPLC HbA1c to determine long term instrument performance. J Diabetes Sci Technol 2009; 3: 424-428.

65. Hicks M, Tough SC, Premji S, Benzies K, Lyon AW, Mitchell I, Sauve R. Alcohol and drug screening of newborns: Would women consent? J Obs Gyn Can 2009; 31: 331-339.

66. Kline G, Weeks S, Lyon A, Jamieson P, Kline RL. A case of acquired salt-wasting orthostasis due to a syndrome of inappropriate cardiac natriuretic peptides secretion. Clin Chim Acta 2009; 401:184-6.

67. James MT, Zhang J, Lyon AW, Hemmelgarn BR. Reduction in misclassification of calcium status through application of a local equation for albumin adjusted calcium. BMC Clinical Pathology 2008, 8:12.

68. Fenton TR, Tanis R Fenton, Michael Eliasziw, Andrew W Lyon, Suzanne C Tough, David A Hanley. A meta-analysis of quantity of calcium excretion associated with the net acid excretion of the modern diet under the acid-ash diet hypothesis Am J. Clin Nutri 2008 88:1159-66

69. Manley SA, Byrns S, Lyon AW, Brown P, Gailer J. Simultaneous Cu, Fe and Zn-specific detection of plamsa metalloproteins by size exclusion chromatography-inductively coupled plasma atomic emission spectroscopy. J Biol Inorg Chem. 2009; 14(1): 159.

70. Hansson P, Lyon A. Hur kan man leva utan albumin? Nagra fall av analbuminemi vacker patofysiologiska fragor How is it possible to live without albumin? Several recent cases of analbuminemia raise physiopathological questions. Lakartidningen 2008; 105(23): 1768-70.

71. Csorba TR, Lyon AW. Abnormal proinsulin congeners as autoantigens that initiate the pathogenesis of Type I diabetes. Medical Hypotheses 2005; 64:186-191.

72. Lyon AW, Larsen ET, Edwards AL. The impact of new guidelines for glucose tolerance testing on clinical practice and laboratory services.CMAJ. 2004 Oct 26;171(9):1067-9.

73. Lyon ME, Ball CL, Krause RD, Slotsve GA, Lyon AW. Effect of hemolysis on cardiac Troponin T determination by the Elecsys. 2010 Immunoanalyzer Clin Biochem 2004; 37(8): 698-701.

74. Newstead J, Card S, Lyon AW. Low serum albumin and abnormal body shape in a young Canadian First Nations woman. Lab Med. 2004; 35(6): 350-356.

75. Lyon AW, Whitley C, Eintracht SL. Analytical evaluation and application of a novel spectrophotometric serum lithium method to a rapid response laboratory. Ther Drug Monit. 2004; 26: 98-101.

76. Hicks M, Sauve RS, Lyon AW, Clarke M, Tough S. Alcohol use and abuse in pregnancy: An evaluation of the merits of screening. Can Child Adol Psych Rev 2003; 12: 77-80.

77. Campagnoli M, Kragh-Hansen U, Overgaard Pedersen A, Amoresano A, Lyon AW, Cesati R, Sala A, Romano A, Galliano M, and Minchiotti L. Structural analysis, fatty acid and thyroxine binding properties of Vancouver and Naskapi variants of human serum albumin. Clin Biochem 2003; 36: 597-605.

78. Lyon ME, Ball CL, Lyon AW, Walpole E, Church DL. A preliminary evaluation of the interaction between urine specific gravity and leukocyte esterase results using Bayer Multistix and the Clinitek 500. Clin Biochem 2003; 35: 579-81.

79. Lyon AW, Baskin LB. Pseudohyponatremia in a Myeloma Patient: Direct Electrode Potentiometry is a Method Worth its Salt. Lab Med. 2003. 34(5): 357-60.

80. Lyon AW, Mayhew WJ. Cesium toxicity: a case of self-treatment by alternate therapy gone awry. Ther Drug Monit. 2003 Feb;25(1):114-6.

81. Zhang Z, Juurlink BHJ, Lyon AW, Paterson PG. Effects of dietary protein and L-2-oxothiazolidine-4-carboxylate on rat brain glutathione concentration. Nutrition Research 2002, 22: 1475-86.

82. Lyon AW, Mansoor A, Trotter MJ. Urinary Gems, Acyclovir Crystalluria , Arch Path Lab Med 2002; 126: 753-4.

83. Galliano M, Campagnoli M, Rossi A, Wirsing von Konig CH, Lyon AW, Cefle K, Yildiz A, Palanduz S, Ozturk S, Minchiotti L. Molecular diagnosis of analbuminemia: a novel mutation identified in two Amerindian and two Turkish families. Clin Chem. 2002 ;48:844-9.

84. Paterson PG, Juurlink BHJ, Lyon AW, Kamencic H, Andersen LB. Sulfur amino acid deficiency depresses brain glutathione concentration. Nutr Neurosci. 2001; 4(3):213-22.

85. Katrusiak A.E, Paterson P.G, Kamencic H, Shoker A, Lyon A.W. A UV-HPLC method for determination of total and reduced cysteine, cystinylglycine, homocystine and glutathione in plasma and cells extracts. J Chromatography B. Biomed Sci Appl (2001) 758: 207-212.

86. Kamencic H, Griebel RW, Lyon AW, Paterson PG, BHJ Juurlink (2001), Promoting glutathione synthesis following spinal cord trauma decreases secondary damage and promotes retention of function. FASEB Journal 15: 243-250.

87. Kamencic H, Lyon A, Paterson P.G., Juurlink BHJ. 2000 Monochlorobimane fluorometric method to measure tissue glutathione Anal Biochem 286:35-7.

88. Lyon ME, Rutledge Harding S, Oosman SN, Lyon AW. 2000 Evaluation of Argatroban and DuP714 as anticoagulants for blood gas, electrolyte and ionized calcium analyses. Scand. J. Clin. Labs. Invest. 60: 19-26.

89. Lyon ME, Drobot DW, Harding SR, Lyon AW.  Evaluation of the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK) with the factor Xa inhibitor 1,5-dansyl-L-glutamyl-L-glycyl-L-arginine chloromethylketone (GGACK)
    as anticoagulants for critical care clinical chemistry specimens.  Clin Chim Acta 1999;280(1-2):91-9.

90. Lyon AW, Meinert P, Bruce GA, Laxdal VA, Salkie ML. Influence of methodology on the detection and diagnosis of congenital analbuminemia. Clin. Chem. 1998; 44: 2365-7.

91. Lyon AW, Rutledge Harding S, Drobot D, Lyon ME. 1997 "Use of thrombin inhibitors ex vivo allows critical care clinical chemistry and hematology testing in common specimens" Clin Biochem 30:121-128.

92. Hindmarsh JT, Lyon AW. 1996. Strategies to improve the utilization of clinical chemistry services. Clinical Biochemistry 29:291-300

93. Lyon ME, Fine JS, Henderson, PJ, Lyon AW. 1995. D-phenylalanyl-L-prolyl-Larginine chloromethylketone
    (PPACK) is an alternative anticoagulant to heparin salts for blood gas, electrolyte and ionized calcium specimens. Clinical Chemistry 41:1038-41

94. Lyon AW, Duran G, Raisys VA. 1995. "Determination of thalidomide by high performance liquid chromatography: methodological strategy for clinical trials". Clinical Biochemistry 28: 467-470

95. Lyon AW, Greenway DC, Hindmarsh JT. 1995. "A strategy to promote rational clinical chemistry test utilization". American Journal Clinical Pathology 103: 718-724

96. Lyon AW, Schaan B, Laxdal VA, Massey KLM. 1995. Evaluation of an Immunoturbidimetric Assay for Hemoglobin Alc. Clinical Biochemistry 28(1): 97-100

97. Lyon AW, Anastassiades T, Kisilevsky R. 1993. In vivo analysis of murine serum sulphate metabolism and splenic glycosaminoglycan biosynthesis during acute inflammation and amyloidosis. Journal of Rheumatology 20:1108-1113

98. Kisilevsky R, Lyon AW, Young ID. 1992. A critical analysis of postulated pathogenic mechanisms in amyloidosis. Critical Reviews in Laboratory Medicine 29:59-82

99. Dow KE, Riopelle RJ, Szarek WA, Bols M, Ison ER, Plenkiewicz J, Lyon A, Kisilevsky R. 1992. Effects of 4-deoxy-L-threo-pentose, a novel carbohydrate on neural cell proteoglycan synthesis and function. Biochimica et Biophysica Acta 1156:7-14

100. Lyon AW, Narindrasorasak S, Anastassiades T, Couchman JR, McCarthy K, Kisilevsky R. 1991. Co-deposition of basement membrane components during the induction of murine splenic AA amyloid. Laboratory Investigation 64:785-790

101. Lyon AW, Kisilevsky R. 1990. Inhibition of the initiation of hepatic protein synthesis during ethionine mediated ATP depletion in vivo: Modification to ribosomal subunits, evidence of impaired ternary complex formation and a subcellular redistribution of eIF-2 alpha. Biochimica Biophysica Acta 1049:158-170

102. Lyon AW, Kisilevsky R. 1986. Changes in glucose metabolism following the administration of ethionine: Its role in regulating hepatic protein synthesis. Toxicological Pathology 14:424-428

Letters to Editors & Newsletter articles.

Lyon AW. Diagnostic accuracy of reference change values. Scand J Clin Lab Invest. 2022; May 26.

Ferraro S, Lyon AW, Braga F, Panteghini M. Definition of analytical quality specifications for serum total folate measurements using a simulation outcome-based model. [Letter to the Editor] Clin Chem Lab Med 2019; Sept 14.doi: 10.1515/cclm-2019-0695.

Prokopchuk-Gauk O, Khan AS, Misskey S, Lyon ME, Lyon AW. Transient Hepatitis B immunity passively acquired from transfusion of packed red blood cells.[Letter to the Editor] Transfus Med 2018;28(6):462-4.

Lyon AW. Which Potassium Do You Believe? Lablogatory. January 2018.

Huntsman, Tang-Wai, Alcorn, Lyon, Mousseau, Seifert, Prosser-Loose, Newmeyer. CARE-E Study: CBD in Children with Refractory Epilepsy. Epilepsy Professional Magazine 2017; 46:12-17.

Dubois JA, Slingerland RJ, Fokkert M, Roman A, Tran NK, Clarke W, Sartori DA, Palmieri TL, Malic A, Lyon ME, Lyon AW. Does Regulatory Really Intersect Reality in Glucose Measurement in the ICU? Is the Issue Testing Method Accuracy or Specimen Type? Crit Care Med 45 (11), e1186-e1188.

Lyon AW, Mukhopadhyay B. The road to Avonlea, from Nadiad GJ, India and Saskatoon. CSCC News 56(5),p1-2.ISSN 0826-1024

Lyon AW. CSCC 3rd Council June 3, 2014 Charlottetown, PEI. CSCC news 2004; 56(4), p3-4. ISSN 0826-1024

Randell E, Lyon A. CSCC pilgrimmage to the IFCC General Assembly in Kuala Lumpur, Malaysia. CSCC News 2013; 55(1), p6-9.

Lyon AW. Comment on Interview on Dr. Wilt and PSA Screening. As It Happens, Canadian Broadcasting Corporation, Oct. 10, 2011. Part 2, 12:38 -13:35.

Lyon AW. Improving the Use of Lab Resources: How CLS reduced the volume of folic acid testing in Calgary. CLS Lab Link Newsletter. June 2011 (Issue 2).

Lyon AW. Could elevated potassium results be due to dehydration?[Letter] MLO Tips from Clinical Experts Medical Laboratory Observer 2011, 43(7): 34-35.

MacDonald AM, Kinniburgh D, Lyon AW. A Novel Designer Drug—Bromo-Dragonfly. Therapeutics & Toxins News, AACC TDM & CT Division, Summer 2011.

Storek J, Vliagoftis H, Grizel A, Lyon A, Daly A, Khan F, Bowen T, Game M, Larratt L, Turner R, Huebsch L. Allergy transfer with hematopoietic cell transplantation from an unrelated donor.[Letter to the Editor] Bone Marrow Transplantation, 2011; 46: 605–606.

LeHotay D, Lyon AW. Clinical and Scientific Leaders Converge on Saskatoon for CSCC. CSCC News Apr 2010, p4-5.

Fenton TR, Eliasziw M, Lyon AW, Tough SC, and Hanley DA. Reply to HM Macdonald et al [Letter to the Editor] Am. J. Clinical Nutrition, Mar 2009; 89: 927

Lyon AW. Acute coronary syndromes. [Letter to the Editor] Lancet. 1999; 354(9181):867.

Lyon AW, Raisys VA. Handling of blood samples for determination of thalidomide. [Letter to the Editor, reply] Clin Chem 1997; 43:1095-6

Lyon AW. 1995. Cost analysis of POC testing. [Letter to the Editor]. American Journal of Clinical Pathology. 104: 107-108.

Lyon AW. 1995. Education in Clinical Chemistry & Internet and the Clinical Biochemist Canadian Society of Clinical Chemists Newsletter, 37(2) : 5-6.

Lyon AW. 1995. MedChem Travelling Lecturer 1994: Dr. H.K.Naito. Canadian Society of Clinical Chemists Newsletter, 36(6):4.

Lyon AW. 1995. Highlights: The Academic Board. Canadian Society of Clinical Chemists Newsletter, 36(4):4.

Invited papers in published conference proceedings

MacDonald AM, Kinniburgh DW,Gabos S, Lee B, Cheung PY, Ackah F, Graydon J, Lyon AW, Jarrell J, Benade G. Biomonitoring of Environmental Chemicals in Pooled Pregnant Women and Cord Blood Serum Samples: Results from the Third Phase of the Alberta Biomonitoring Program.Organohalogen Compounds. 2018; 80:425-428.

Ooi DS, Lyon AW, Ooi TC. 1991. Relationship of rate nephelometric-analysed serum apolipoprotein A1 and B with cholesterol utilized as a means of quality control. 5th Asian-Pacific Congress of Clinical Biochemistry, Kobe, Japan, 29 September-4 October. Progress in Clinical Biochemistry 73-75

Lyon AW, Narindrasorasak S, McCarthy K, Couchman JR, Kisilevsky R. 1990. Basement membrane components in addition to HSPG are present in murine AA amyloid deposits. VIth International Symposium on Amyloidosis, Oslo, Norway, 5-8 August. Proceedings of the VIth International Symposium on Amyloidosis, Pergamon Press, New York, NY.

Abstracts and Poster Presentations

1. Amy M.MacDonald, Sylvia Tiu1, Penny Colbourne2, Andrew W. Lyon3, and David W. Kinniburgh1,4 Assessment of Trace Metal Contamination in Blood Collection Tubes and Storage Containers for Human Biomonitoring Studies. 22nd International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Banff, Canada, September 15-18, 2024. 

2. Oliver AS Lyon, Michael Szafron, Martha E Lyon, Andrew W Lyon.  Effect of Analytic and Biologic Variation of Plasma Creatinine on Classification of Chronic Kidney Disease Stages using the CKD-EPI 2021 eGFR Equation. in: Selected abstracts presented at the annual conference of the Canadian Society of Clinical Chemists (CSCC), 2023. Clinical Biochemistry 121-122; 2023: 1106-1146.

3. Michael Szafron, Oliver AS Lyon , Andrew W Lyon , Martha E. Lyon. Comparison of the CKD-EPI 2009 and 2021 equations to screen for chronic kidney disease stages using a NHANES dataset. in: Selected abstracts presented at the annual conference of the Canadian Society of Clinical Chemists (CSCC), 2023. Clinical Biochemistry 121-122; 2023: 1106-1146.

4. Kazem Nouri, Matthew Lafreniere, Lorna Clark, Joshua D. Buse, Kayode Balogun, Viktor Skihar, Mark Cheung, Barry Hoffman, Jennifer Taher, Daniel R. Beriault, Yun Huang, Albert Tsui, Joshua E. Raizman, David Blank, Shaun Eintracht, Rose Djiana, Ching T. Mark, Andrew W. Lyon, Michael X. Chen, Angela Fung, Janet Simons, Andre Mattman, Laurel Thorlacius,  Ronald A. Booth,  Christopher McCudden, Vipin Bhayana, Joël Lavoie, Jennifer Shea, Amy Lou, Vathany Kulasingam, Julie St-Cyr, Chantele Roy, Paul Malinowski, Nicholas L Mills, Karin H Humphries, Peter Kavsak. Multi-site imprecision for the Abbott, Beckman, Roche and Siemens high-sensitivity cardiac troponin assays at the female 99th-percentile: a sub-study of the CODE-MI stepped-wedge cluster-randomized trial. AACC Annual Meeting, Chicago, IL, USA. July 2022.

5. Kazem Nouri, Joshua Buse, Kayode Balogun, Viktor Skihar, Chi-Yiu Mark Cheung, Barry Hoffman, Jennifer Taher, Daniel R. Beriault, Yun Huang, Albert Tsui, Joshua Raizman, David Blank, Shaun Eintracht, Rose Djiana, Ching T. Mark, Andrew Lyon, Michael X. Chen, Angela W.S. Fung, Janet Simons, Andre Mattman, Laurel Thorlacius, Ronald A. Booth, Christopher McCudden, Vipin Bhayana, Joël Lavoie, Jennifer Shea, Amy Lou, Vathany Kulasingam, Julie St-Cyr, Lorna Clark, Peter Kavsak. A national study to evaluate analytical performance specifications for high-sensitivity cardiac troponin assays. CSCC Annual Meeting, Niagara Fall, ON, Canada. June 2022.

6. Andrew Lyon, Kazem Nouri, Michael Chen, Angela W.S. Fung, Janet Simons, Andre Mattman, Albert Tsui, Josh Raizman, Laurel Thorlacius, Chi-Yiu Mark Cheung, Ronald A. Booth, Christopher McCudden, Vipin Bhayana, Barry Hoffman, Jennifer Taher, Joël Lavoie, Shaun Eintracht, Jennifer Shea, Amy Lou, Lorna Clark, Peter Kavsak. Multisite evaluation of high-sensitivity cardiac Troponin T with patient pools on different Roche analyzers: Interim report on observed components of variance. CSCC Annual Meeting, Niagara Fall, ON, Canada. June 2022. 

7. Kyle B, Bajkov A, Haugrud D, Wu F, Lyon A, Lyon M. M125 Simulation models to predict biochemistry test capacity in Covid-19 pandemic surge capacity planning in tertiary care centres.  IFCC WorldLab, Seoul, Korea. June 2022. Clin Chim Acta 2022; 530: S258. 

8. Lyon AW, Lyon ME. Evaluation of Electrode Maintenance and Quality Control for Ionized Calcium to Support Post-Filter Testing During Continuous Renal Replacement Therapy (CRRT) With Regional Citrate Anticoagulation .  AACC / CSCC Annual Meeting, Atlanta, GA, USA. Sept 28, 2021.

9. Cembrowski G, Qiu Y, Lyon A, McCudden C, Holmes D, Sadrzadeh H, Cervinski M. Reference change values of hospitalized patients differ from those of healthy subjects: It's time to get real. AACC / CSCC Annual Meeting, Atlanta, GA, USA. Sept 28, 2021.

10. Arenson B, Lyon AW, Shah S. A case for a healthy dose of skepticism. Canadian Society for Internal Medicine. Halifax, NS, Canada. Oct 2019.

11. MacDonald AM, Kinniburgh DW, Gabos S, Lee B, Cheung P, Ackah F, Reichert M, Graydon J, Lyon AW, Jarrell J, Benade G. An overview of three phases of the Alberta biomonitoring Program. 11th Int Symp. on Biological Monitoring in Occupational and Environmental Health. Leuven, Belgium. Aug 2019.

12. Stephanie Vuong, Deborah Michel, Richard Huntsman, Andrew W Lyon, and Jane Alcorn. Determining plasma protein binding profiles of bioactive cannabinoids in human plasma. Cannabinoid Research Initiative of Saskatchewan - Symposium. Saskatoon, SK, Canada. August 2019.

13. McPherson J, Ethier D, Wu F, Lyon AW, Lyon ME. Can ethylene glycol metabolites be detected using a point of care lactate meter to assess the lactate gap? A case study. Amer Assoc Clin Chem. Anaheim,CA,USA. Aug 2019.

14. Paul H, Lyon AW, Lyon ME, Wu F. Evaluation of cyclosporine, tacrolimus and sirolimus immunoassays on Roche cobas e801 analyzers. CSCC Annual Meeting, Saint John, NB, Canada. June 2019.

15. Vuong S, Michel D, Huntsman R, Lyon AW, Alcorn J. Developing a Dried Blood Spot Assay for Detecting Prenatal Cannabis Exposure in Newborns. CSPS May 2019.

16. Stephanie Vuong, Deborah Michel, Richard Huntsman, Andrew W Lyon, and Jane Alcorn. Development of a Dried Blood Spot Assay for Detecting Prenatal Cannabis Exposure in Newborns. Child Health Trainee Day, Univ Sask. Saskatoon, SK, Canada April 26, 2019.

17. Stephanie Vuong S, Michel D, Huntsman R, Tang-Wai R, Wu F, Lyon AW, and Alcorn J. Development and Validation of a LC-MS/MS Method for Bioactive Cannabinoids in Plasma of Pediatric Patients on Cannabis Oil Therapy. American Association of Pharmaceutical Scientists, PharmSci 360, Washington, DC. Nov 2018.

18. Leis B, Frost A, Bryce R, Lyon AW, Coverett K. Altering standard admission order sets to reduce low value blood testing: a prospective cross-sectional study. Canadian Cardiovascular Congress - Toronto, ON, Canada Oct 2018.

19. Lyon OAS, Lyon ME, Lyon AW, Dubois JA, Tran NK. Impact of HbA1c analytic error on classification of patients using American Diabetes Association diagnostic criteria. Adv Tech & Trt Diabetes, Berlin, Ger. Feb 2019.

20. Lyon OAS, Lyon ME, Lyon AW, Dubois JA, Tran NK. Imapct of glucose analytic error on risk of misclassification of patients using American Diabetes Association criteria. Adv Tech & Trt Diabetes, Berlin, Ger, Feb 2019.

21. Leis B, Frost A, Bryce R, Lyon AW, Coverett K. Altering standard admission order sets to reduce low value blood testing: a prospective cross-sectional study. Canadian Cardiovascular Congress - Toronto, ON, Canada Oct 2018.

22. Lyon ME, Lyon OAS, Tran NK, DuBois JA, Lyon AW. Clinical risk of using the Nova StatStrip glucose meter in a critically ill patient population: Analysis with the Surveillance and IDEA error grids. CPCOT Washington, DC, USA Sept 2018.

23. Lyon ME, Lyon OAS, Tran NK, DuBois JA, Lyon AW. Assessment of the clinical risk of the Nova StatStrip glucose meter using the insulin dose error assessment (IDEA) grid. CPCOT Washington, DC, USA Sept 2018.

24. Lyon ME, Lyon OAS, Tran NK, DuBois JA, Lyon AW. Assessment of the perchloric acid hexokinase and plasma glucose oxidase methods using glucose error grids.CPCOT Washington, DC, USA Sept 2018.

25. Vuong S, Michels D, Huntsman R, Tang-Wai R, Wu F, Lyon AW, Alcorn J. Development and Validation of a LC-MS/MS Method for Bioactive Cannabinoids in Plasma of Pediatric Patients on Cannabis Oil Therapy. 2018 Cannabinoid Research Symposium. Cannabinoid Research Initiative of Saskatchewan, Saskatoon, SK, Canada. Aug 16-17, 2018.

26. Wu F, Lyon AW, Kakdekar AA, St Germaine K,, Lyon ME. Pneumatic tube delivery of whole blood specimens affects the measurement of lactate dehydrogenase, total CO2 and anion gap. AACC Annual Meeting- Chicago, IL, USA. July 2018.

27. Lyon ME, Lyon OAS, Tran NK, DuBois JA, Lyon AW. A novel tool to relate glucose meter performance to clinical outcome: The Insulin Dose Error Assessment (IDEA) Grid. AACC Annual Meeting-Chicago, IL, USA. July 2018.

28. Lyon AW, Wu F, Gebhardt C, Lyon ME. Indirect drug-medicated creatine interference with whole blood creatinine sensor in the ABL837 FLEX analyzer during necrotizing fasciitis and shock. CSCC Ottawa, June 2018.

29. Wu F, Lyon AW, Kakadekar AA, St Germaine K, Lyon ME. Pneumatic tube delivery of whole blood specimens affects measurement of lactate dehydrogenase, total CO2 and anion gap. CSCC Ottawa, June 2018.

30. Tang-Wai R, Seifert B, Lyon AW, Alcorn J, Acton B, Corley S, Prosser-Loose, Mousseau DD, Laprairie R, Lim HJ, Tellez-Zentino J, Huntsman RJ.Cannabidiol Enriched Cannabis Herbal Extract in pediatric patients with refractory epileptic encephalopathy-The CARE-E study. Canadian College of Neuropsychopharmacology 41st Annual Meeting, Vancouver, BC. June28-30, 2018.

31. Vuong S, Michel D, Huntsman R, Tang-Wai R, Wu F, Lyon AW, Alcorn J. Development of a liquid chromatography-tandem mass spectrometry assay for analysis of bioactive cannabinoids in plasma of pediatric patients on cannabis oil therapy. MSACL 2018 US. Palm Springs, CA, USA. Jan 21, 2018.

32. Sielski A, Newstead-Angel J, Lyon A. Assessing postpartum glucose screening rates for gestational diabetes in the Saskatoon Health Region. SOGC/APOG Ontario CME 2017, Toronto, ON, Nov 2017.

33. Lyon ME, Kavsak PA, Lyon AW. The Effect of Heparin on Measurement of High Sensitivity Cardiac Troponin I: Influence on Diagnostic Misclassification at Decision Thresholds. 69th AACC Annual Scientific Meeting, 2017. A-064; S24.

34. Andrews AR, Lyon AW, Lyon ME. Heads up! Fetal scalp lactate misclassification error rates based on simulation modelling for the Lactate Pro meter.  69th AACC Annual Scientific Meeting, 2017. B-247; S249.

35. Lyon ME, Sinha R, Lyon OAS, Lyon AW. Application of a Monte Carlo simulation model to estimate clinical risk associated with the analytic performance of point of care INR Devices. 69th AACC Annual Scientific Meeting, 2017. B-273; S259.

36. Lyon ME, Kavsak PA, Worster A, Lyon AW. Simulation Models to Rule-Out Acute Myocardial Infarction with Two Point of Care Testing Devices and a High-Sensitivity Cardiac Troponin T Method. 69th AACC Annual Scientific Meeting, 2017. B-276; S260.

37. Lyon ME, Lyon AW. Analytic Evaluation of the b101 Hemoglobin A1c Point of Care Testing Method from Roche Diagnostics.  69th AACC Annual Scientific Meeting, 2017. B-299; S267.

38. Poonja Z, Uppal J, Bryce R, Lyon AW, Cload B. Quantifying Residual Blood Contamination of Ultrasound Probes after use in Trauma. Sasksono17: Clinical Ultrasonography Conference, Saskatoon, SK. April 2017.

39. Prokopchuk-Gauk O, Khan AS, Misskey S, Lyon ME, Lyon AW. Transient hepatitis B immunity acquired from transfusion of packed red blood cells: a case report depicting practice guideline rationale. Can Soc. Trans. Med, Ottawa, June 2017.

40. Uppal J, Poonja Z, Bryce R, Lyon A, and Cload B. Identifying Residual Blood Contamination of Ultrasound Probes after use in Trauma. College of Medicine, Univ. Saskatchewan. Deans Summer Student Research Award. Saskatoon 2016.

41. Heng YJ, Pennell CE, McDonald SW, Vinturache AE, Xu J, Lee MWF, Briollais L, Lyon AW, Slater DM, Bocking AD, Tough SC, Lye SJ. Maternal Whole Blood Gene Expression Predicts Spontaneous Preterm Birth in Asymptomatic Women as Early as 18 Weeks Gestation. Conference: Reproductive Sciences 2015; Vol 22, 59A.

42. Lyon AW, Mukhopadhyay B. Analysis of hemoglobin variation among acute care patients through data mining: walking the path to integration of laboratory medicine. Ind J Clin Biochem. 2014; 29 (Suppl 1): 40.

43. Lyon M, Isbell TS, DuBois J, Fokkert M, Slingerland R, Lyon A. The impact of low concentrations of galactose on the performance of modified PQQ-GDH glucose meters to detect hypoglycemia. Diabet Technol & Ther 2014; 16: A139.

44. DuBois, J. A., Lyon, M. E., Lyon, A. W., Slingerland, R. J., Fokkert, M., Roman, A., … Sartori, D. (2014, September). Comparison of four models for assessing insulin dosing error when a blood glucose monitoring system is used in various patient populations. American Association for Clinical Chemistry, Critical and Point-of-Care Testing Division, San Diego, CA.

45. Malic, A., Lyon, M. E., Lyon, A. W., Slingerland, R. J., Fokkert, M., Roman, A., … DuBois, J. A. (2014, October). International multi-site evaluation of a hospital POC blood glucose monitoring system in critically ill patients: Assessment of clinical risk using insulin dosing error models. Werkgroep POCT van de Nationale Commissie Klinische Biologie, Antwerp, Belgium.

46. Lyon ME, Isbell TS, Dubois JA, Fokkert M, Slingerland RJ, Lyon AW. A mathematical model to determine the impact of low concentrations of galactose on the performance of glucose meters. 7th International Conference on Advanced Therapies and Treatments for Diabetes, Vienna, Austria Feb 5-8, 2014.

47. Lyon ME, Dubois JA, Slingerland RJ, Lyon AW. Impact of the comparitive method on the outcome of a glucose meter evaluation. 7th International Conference on Advanced Therapies and Treatments for Diabetes, Vienna, Austria Feb 5-8, 2014.

48. Metcalfe A,Lix L, Bernier F, Currie G, Lyon A, Johnson J, Tough S. Impact of under-ascertaining comorbid conditions at delivery on estimated disease prevalance in a pregnant population. Am J Epi 2013; 177: S78.

49. Metcalfe A, Johnson J, Bernier F, Lix LM, Currie G, Lyon AW, Tough SC. Utilization of first and second trimester prenatal screening tests in a population-based pregnancy cohort. 2012.

50. Metcalfe A, Lyon A, Johnson J, Bernier F, Currie G, Lix L, Tough S.Linkage of Clinical and Administrative Data to
    Identify a Conception Cohort. WHO-Family of International Classifications -Annual Meeting, Cape Town, South Africa, Oct 29, 2011.

51. Lyon ME, Dubois J, Slingerland RJ, Dikkeschei LD, Lyon AW. Theoretical Impact of Detecting Whole Blood Glucose Molality and Reporting Plasma Glucose Molarity in Various Patient Populations. 2011 International Hospital Diabetes Meeting, Nov 17 – 19, 2011. Barcelona, Spain.

52. MacDonald AM, Zhang X, Kinniburgh DW, Lyon AW. Reduction of Oxazepam to Nordiazepam and Temazepam to Diazepam in the Urine of Drug Rehabilitation Program Patients 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, October, 2011. Stuttgart, Germany.

53. Chin AC, Lyon ME, Slotsve GA, Lyon AW. Further development of a mathematical model to predict the onset of iatrogenic anemia induced by repetitive phlebotomy in critical care patients. AACC Abstract Atlanta July 2011.

54. Chin AC, Lyon ME, Slotsve GA, Lyon AW. Mathematical estimation of iatrogenic anemia onset due to repetitive diagnostic blood loss in critical care patients. CSCC Vancouver, BC, June 2011. Clin Biochem 2011; 44: 1168-1169.

55. Drewniak M, Fenton TR, Lyon AW. What are the Best Fat Removal Methods in Making Low Fat Milk for Infants with Chylothorax? ASPEN Meeting Vancouver Jan 29, 2011

56. Straseski J, Lyon ME, Clarke W, Dubois JA, Lyon AW. Point-of-care whole blood creatinine analyses are influenced by
    matrix components of whole blood. 12th Asian-Pacific Congress of Clinical Biochemistry, Seoul, Korea. Oct 2010. p85 Congress Program.

57. Fenton TR, Lyon AW, Antunes A, Rose MS. Calcium phosphate, magnesium, and alkaline phophatase laboratory reference intervals for preterm infants.  Dietitians of Canada 13th Annual Conference,Montreal PQ, May 27-29, 2010. 2010:135.

58. Fenton TR, Lyon AW, Rose MS, Antunes A. Calcium phosphate, magnesium, and alkaline phophatase laboratory reference intervals for preterm infants.  Proceedings Canadian Nutrition Society,Edmonton AB, June 3-5, 2010. 2010:288

59. Lyon ME, Lyon AW. Predicted discrepancies between direct reading whole blood biosensors and central lab plasma methods: Predicting and avoiding medical error. AACC Point of Care Testing Conference, Boston, Sept 2010.

60. Lyon ME, Dubois JA, Fick GH, Lyon AW. Estimates of total analytical error in consumer and hospital glucose meters contributed by hematocrit, maltose and ascorbate. AACC Point of Care Testing Conference, Boston, Sept 2010.

61. Lyon AW. Updated case studies on recognition and assessment of assay interference.[Roundtable Presentation]. Canadian Society of Clinical Chemists Annual Meeting, Saskatoon, SK, June 13-16. 2010.

62. Gracie SK, Tough SC, Lyon AW, Pennell CE, Dolan SM, Lye SJ, Bocking AD, Olson DM. All our babies prediction of preterm birth study: A transdisciplinary transcriptomic approach to predict preterm birth. 18th Annual Western Perinatal Research Meeting, Banff, AB. Feb. 2010.

63. Pollak PT, Lyon AW, Verjee ZH. Rapid resolution of ripseridone induced QT prolongation following overdose - no evidence for delayed elimination of supratherapeutic dosing. Can J Cardiol 2009; 25 (Suppl B): 686.

64. Pollak PT, Lyon AW, Verjee ZH. Risperidone induced QT prolongation following overdose correlates with serum drug concentration and resolves rapidly with no evidence of altered pharmacokinetics. Clin Pharmacol Ther 2010; 87 (suppl 1): S41.

65. Lyon ME, Gray d, Dubois JA, Baskin LB, Lyon AW. Impact of Patient Hematocrit on Glucose Meter Performance. Diabetes Technology Conference, San Fransisco. Oct 2009.

66. Cembrowski GS, Tran DV, Lyon AW, Tandem Roche Hitachi 917 and Tandem Beckman LX-20 operated in two tertiary care hospitals exhibit comparable total patient-based imprecisions. Clin Chem 2009; 55: A105.

67. Khan, Faisal; Ueno-Yamanouchi, Aito; Serushago, Bazir; Bowen, Tom; Lyon, Andrew W; Lu, Cathy; Storek J. Basophil activation test compared to skin prick test and fluorescent enzymoimmunoassay for aeroallergen-specific IgE. Clin Immunol: 131 (Supp. 1), 2009; S145.

68. Fenton TR, Hanley DA, Eliasziw M Lyon AW. Tough S. The Association of Urine Measures of Diet-derived Acid Excretion with Bone Loss and Fractures: CaMOS Study. J Bone Min Res 23: S312-S312 Suppl. S 2008.

69. Fenton TR, Hanley DA, Eliasziw M Lyon AW. Tough S. Osteoporosis and the Acid-ash Hypothesis: Evidence Based on Bradford Hill's Criteria for Causality. J Bone Min Res 23: S196-S196 Suppl. S 2008.

70. Wesenberg JC, Higgins TN, Cembrowski GS, Tran DV, Lyon AW. A tale of HbA1c utilization in 4 Alberta cities. Clin Biochem 2008; 41: 1286.

71. Tran, DV; Lyon, AW; Higgins, TN, et al. Patient-derived long-term total analytic performance of Roche Integra 700, Roche Integra 400 and Dade Dimension RxL HbA1c immunoassays approach HPLC
    CLINICAL CHEMISTRY 54(6): A120-A120, 2008.

72. Dias, VC; Lyon, AW Correction for ethanol compromises the sensitivity of the osmolar gap to predict the presence of toxic alcohols: An observational study. CLINICAL BIOCHEMISTRY 41: 191-191: 2008.

73. Hicks M, Tough S, Lyon A, Premji S, Benzies K, Savue R, MEC Study Team. Under what conditions would mothers consent to alcohol and drug screening of their newborns? Adv. Neonatal Care. 7(1): 50-51.2007

74. Zielke S, Ho NM, Lyon A, Abrahams Z, Warnica JW, Isaacs D. Adverse cardiac events and resource utilization in emergency department patients with symptoms of congestive heart failure and a low B-type natriuretic peptide (BNP) level: A prospective case series. Can J Cardiol 23: 193C Suppl C. 2007.

75. Flo NM, Zielke S, Smith H, Lyon A, Warnica JW, Isaacs DL. Comparison of the accuracy of BNP, NT-proBNP and emergency physicians in the diagnosis of heart failure in patients presenting with shortness of breath. Can J Cardiol 23: 193C, Suppl C. 2007.

76. Budd C, Krause RD, Lyon AW, Lyon ME. To acidify or not to acidify (urine): That is the question!. Clin Biochem 39(11): 1105. 2006

77. Hicks M, Tough S, Lyon A, Premji S, Benzies K, Mitchell I, Sauve R. Under what conditions would mothers consent to alcohol and drug screening of their newborns? E-Pediatric Academic Society 2006;59:3571.314

78. Hicks M, Tough S, Lyon A, Premji S, Benzies K, Mitchell I, Sauve R. Alcohol and drug screening of newborns: conditions for maternal consent. Clinical and Investigative Medicine 2006;29(4):270.

79. Andrew W. Lyon, Janice James, Christine Lemaire, Bruce Culleton. Accurate laboratory results and reduction in labor using a multiple aliquot method to assess peritoneal dialysis adequacy in patients receiving CAPD Western Canadian Peritoneal Dialysis Days. Calgary, AB. Sept. 2004.

80. Antunes M, Fenton T, Lyon AW. Gestational-age specific reference ranges for markers of bone metabolism and renal function derived from umbilical cord blood Pediatric Research 55; 385A-385A 2189 Part 2 Suppl. S, APR 2004

81. Lyon, M.E., Hooper, T.A., Holden, T., Anderson, I., Lyon, A.W., and Wainer, S. Accuracy of the bilichek transutaneous bilirubinometer for the detection of neonatal hyperbilirubinemia using Canadian pediatric society diagnostic guidelines.Canadian Society of Clinical Chemists Annual Meeting, London, ON. June 2004.

82. Allegro, D.R., Stephenson, M.L., Nicholaichuk, S., Lyon, A.W., Church, D.L. and Lyon, M.E. Evaluation of the Bayer Clinitek 500 and the Multistix 8 SG dipstick to predict microscopic red blood cells in urine sediment. Canadian Society of Clinical Chemists Annual Meeting, London, ON. June 2004.

83. Martha E. Lyon, Andrew W. Lyon, Cheri Nijssen-Jordan, Charles M. Coleman. Can Chemistry and Hematology Laboratories Use a Common Blood Specimen? Genesis of Clinical Laboratory Integration 20th International Symposium on Critical Care and Point-fo-Care TEsting. Wurzburg, Germany, June 2004.

84. Lyon ME, Ball CL, Montgomery MD, Lyon AW. Diagnostic accuracy of sweat chloride and sweat sodium in the detection of cystic fibrosis compared to CFTR mutation analysis: A retrospective pediatric study. IX International Congress on Pediatric Laboratory Medicine, International Association of Pediatric Laboratory Medicine. Sept. 2003. Rome, Italy.

85. Vroegindewye A, Dalgleish S, Benzies K, Snozyk S, Lyon AW. Analytical evaluation of point-of-care glucose testing devices for use in neonatal intensive care. Clin Biochem.2003; 36: 487.

86. Lyon AW, Whitley C, Eintracht SL. Analytical evaluation of a novel serum lithium method in a rapid response laboratory. Clin Biochem 2003; 36: 493.

87. Simon V, Wells J, Yong VW, Herman RJ, Lyon AW. Microanalysis of serum minocycline by high performance liquid chromatography: applications to murine and human pharmacokinetic studies. Clin Biochem 2003; 36: 493

88. Simon V, Tough S, Johnston DW, Pollard J, Lyon A.W. (2002). Gas chromatography-mass spectrometry method for simultaneous determination of nicotine and cotinine in fetal and maternal plasma and urine from pregnant smokers using transdermal nicotine replacement therapy. Clin. Biochem. 35: 165

89. Haydon,CM, Tesanovic M, Lyon, AW. (2002) Multi-component diode array second-derivative spectrophotometric deter-mination of urine coproprophyrin and uroporphyrin. Clin. Biochem 35: 155

90. Lyon AW, Lyon ME (2002) Do we ever take too much blood? A mathematical model of iatrogenic anemia that indicates the influence of repetitive diagnostic phlebotomy on adult critical care patients. Clin. Biochem. 35: 163

91. Winfield S, Lyon AW (2002) Development of custom amniotic fluid bilirubin Liley reports with gestational-age specific reference ranges and percentage Liley zone 2 intervals to aid evaluation of Rh disease in utero. Clin. Biochem. 35: 151.

92. Kamencic H, Griebel RW, Lyon AW, Paterson PG, Matshes E and BHJ Juurlink, Promoting glutathione synthesis following spinal cord trauma decreases secondary damage and promotes retention of function. 7th Annual Life Sciences Research Day, January/2000, Saskatoon.

93. Kamencic H, Lyon AW, Griebel, RW Matshes, EW, Kelly M, Paterson PG, BHJ Juurlink (2000). The pro- cysteine compound L-2-oxothiazolidine-4-carboxylate promotes retention of function following spinal cord trauma. Restorative Neurology and Neuroscience 16 (3,4) p287.

94. Kamencic H, A.W.Lyon, P.G.Paterson, R.W.Griebel and B.H.J.Juurlink, There is rapid onset of oxidative stress following compression-induced spinal cord injury, Soc. Neurosci. Abstr., 25, 1329 (1999)

95. Kamencic H, Lyon AW, Paterson PG, Griebel RW, BHJ Juurlink. Oxidative stress following spinal trauma can be ameliorated by procisteine compounds, The Seventeenth Annual National Neurotrauma Society Symposium, J Neurotrauma, 1999 16 (10) p.975

96. Kamencic H, A.W.Lyon, P.G.Paterson, R.W.Griebel and B.H.J.Juurlink, Traumatic spinal cord injury results in rapid onset of oxidative stress, 6th Annual Life Sciences Research Day, Saskatoon, 1999.

97. Lyon ME, Rutledge Harding S, Lyon AW. 1999 Use of selective thrombin inhibitor, D-phenylalanyl-L-Prolyl-L-arginine-chloromethylketone (PPACK) with a factor Xa inhibitor, 1, 5-Dansyl-L-glutamyl-L-glycyl-L-Arginine chloromethylketone (GGACK) for the preservation of blood cells and platelets ex vivo. Clin Biochem. 32: 295.

98. Zhang Z., Lyon AW, Paterson PG. 1999 The influence of dietary protein of brain glutathione concentration in relation to stroke. The 5th Altschul Symposium and 4th WHO Summer School, Saskatoon, SK. August.

99. Kamencic H, Lyon AW, Paterson PG, Juurlink BHJ. 1998 Traumatic spinal cord injury results in rapid onset of oxidative stress. Society for Neuroscience Annual Meeting, Los Angeles, CA. Soc. Neurosci 24: 1166.

100. Kamencic H, Lyon AW, Juurlink BHJ. 1998. Comparison of two methods to determine reduced-glutathione (GSH) content of rat liver. 5th Internet World Congress for Biomedical Sciences. (www.mcmaster.ca/inabis98)

101. Paterson PG, Juurlink BHJ, Lyon AW. 1998. Regulation of brain glutathione concentration by dietary sulfur amino acids. Society for Neuroscience Annual Meeting, Los Angeles, CA. Soc. Neurosci 24: 1167.

102. Lyon AW, Meinert P, Bruce GA, Laxdal VA, Salkie ML. 1998. The influence of methodology on the diagnosis of congenital analbuminemia. Clin Biochem. 31:296.

103. Katrusiak AE, Shoker AS, Lyon AW. A sensitive uv-hplc method for the determination of sulfhydryl and disulfide amino acids in human plasma. Clin. Biochem. 1997; 30: 375.

104. Lyon AW, Rutledge Harding S, Drobot D, Lyon ME. Use of thrombin inhibitors ex vivo allows critical care clinical chemistry and hematology testing on common specimens. in Significant Advances in Critical Care Testing, ed. M. Muller, W. List, M.J.McQueen, Springer Verlag (Heidelberg,1997)pp 223-4.

105. Lyon AW, Rutledge Harding S, Drobot D, Lyon ME. Evaluation of Concord calcium neutralized dry lithium heparin Pro-Vent blood gas syringes for determination of blood gases, electrolytes and ionized calcium. Clinical Chemistry 1996; 42: S279.

106. Drobot D, Rutledge Harding S, Lyon AW, Lyon ME. Use of a thrombin inhibitor,
     D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK) with a factor Xa inhibitor, 1,5-dansyl-L-glutamyl-L-glycyl-L-arginine chloromethylketone (GGACK) for anticoagulation of clinicalchemistry specimens. Clinical Chemistry 1996; 42: S278.

107. Hofgartner WT, Duran G, Lyon AW, Raisys VA. 1995. Quantitative determination of thymidine triphosphate by reversed phase high performance liquid chromatography with bioluminescent detection. American Journal Clinical
     Pathology: 104: 217.

108. Lyon ME, Fine JS, Henderson PJ, Lyon AW. 1995. Evaluation of a novel anticoagulant, D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK) on blood gas, electrolyte and ionized calcium analyses. Clinical Biochemistry 28:338

109. Lyon AW, Lyon ME. 1995. Comparison of anticoagulant bias with aspartate transaminase (AST), amylase, creatine kinase (CK) and creatine kinase MB (CK-MB) analyses on the kodak ektachem 700 analyzer. Clinical Biochemistry 28:338-339.

110. Lyon AW, Duran G, Raisys VA. 1994. Determination of thalidomide in human plasma: Methodological design for clinical trials. Clinical Biochemistry 27:209

111. Pereira CM, Lyon AW, Unadkat JD, Raisys VA. 1993. Simultaneous determination of dideoxyinosine (DDI) and zidovudine (ZDV) in human plasma by HPLC. Clinical Chemistry 39:1231

112. Lyon AW, Greenway DC, Hindmarsh JT. 1993. Strategies to promote cost-effective biochemistry test ordering. Clinical Biochemistry 26:132

113. Hindmarsh JT, Greenway DC, Lyon AW. 1993. Techniques to improve biochemistry test ordering practices. Clinical Investigative Medicine, Volume 16, Supplement:B86

114. Lyon ME, Lyon AW, Toivola B. 1993. Concordance of clinical thyroid status with thyroid function tests: A quality assurance program. American Journal Clinical Pathology 100:174

115. Lyon AW, Anastassiades T, Kisilevsky R. 1991. In vivo analysis of murine splenic glycosaminoglycan biosynthesis and sulphate metabolism during acute inflammation. Clinical Chemistry 37:1069

116. Dow K, Riopelle R, Bols M, Ison ER, Szarek WA, Lyon AW, Kisilevsky R. 1990. Effects of a novel carbohydrate, 4-deoxy-L-threo-pentose on neural cell proteoglycan synthesis and function. Neurobiol of Aging 11(3): 307. 1990.

117. Lyon AW, Kisilevsky R. 1988. Analysis of hepatic ribosomes, ribosomal subunits and initiation factor two (eIF-2) during acute ethionine intoxication of the rat. FASEB Journal 2:A777

118. Lyon AW, Kisilevsky R. 1985. Regulation of hepatic protein synthesis: The role of insulin and glucagon during acute ethionine intoxication. Laboratory Investigation 52:40A
     
     Technical Reports
     
     Villanueva M, Tenn C, Caulkett N, Lyon A, Lyon M, Semple H. Development of an anesthetized swine model of hemorrhage. Phase 2 report  Controlled Hemorrhage.  Defence Research and Development Canada Scientific Report. DRDC-RDDC-2024-R151, December 2024.

Villanueva M, Tenn C, Caulkett N, Lyon A, Lyon M, Semple H. Development of an anesthetized swine model of hemorrhage. Phase 1 report Evaluation of an anesthetic protocol. Defence Research and Development Canada Scientific Report. DRDC-RDDC-2023-R086, July 2023.

Fireball  Report.     AndrewL   Nov 22, 2021.  Saskatoon, SK, Canada.

Unadkat J, Raisys V, Lyon AW, Collier AC. 1994. Intracellular pharmcokinetics of zidovudine triphosphate after single and multiple dose administration of zidovudine - A substudy to ACTG 276. A.C. Concept Sheet October . Aids Clinical Trial Group, NIH , Rockville, MD, U.S.A.

Videos, Media and Electronic Publications

Cannabinoid Research Initiative of Saskatchewan CRIS (2017-2021) Website

BMC Series Blog - Interview: Interdiciplinary studies on preterm birth: Creating a legacy of team research. Jan 31, 2013.

Preterm Birth and Healthy Outcomes Team: AIHS Video. Andrew Lyon PhD PreHOT [Video online] 2011

The International Federation of Clinical Chemistry and Laboratory Medicine Website. www.ifcc.org. (2009 - 2012).

The Department of Pathology and Laboratory Medicine, University of Calgary. www.ucalgary.ca/UofC/faculties/medicine/PATH/ (2000-2002).

The Canadian Academy of Clinical Biochemistry Website www.cscc.ca/academy/ (1999-2001)

The Canadian Society of Clinical Chemists Website: www.cscc.ca (1996-2001)

Video Interview: Canadian Society of Clinical Chemist's 50th Anniversary Founding Member Interviews ( 5 DVD set, David Robert Productions 2006). Interview of Dr. Allan Trew by Andrew Lyon, DVD #5, ( 28 min).

The Department of Pathology University of SaskatchewanWebsite: www.usask.ca/medicine/pathology. (1995-2000).

Blood coagulation retardants and devices. Patent Application / Abstract. WO1995014788 A1

Invited Lectures

Lyon AW. Statistical measures of variation applied in practices of clinical laboratories: Historical practices & future directions. Workshop. CSCC Annual Meeting, Niagara Fall, ON, June 2022. 

Lyon AW. CARE-E clinical trial of cannabis oil in children with epilepsy. Saskatchewan Society of Medical Laboratory Technologist's Fall Meeting, Saskatoon, SK. Sept 28, 2018.

Lyon AW. Lab struggles and strategies for assessing calcium status: the unfolding story of ionized calcium tests. Newfoundland & Labrador College of Medical Laboratory Sciences Fall Symposium. Clarenville, NL, Oct 15, 2016.

deFilippi C, Lyon AW. Transitioning Your Institution to Next Gen Troponin T. AACC Annual Meeting, Industry Workshop, July 28th, 2015. Atlanta, GA.

Lyon AW. The influence of future trends on laboratory medicine: Adaptation or natural selection? AACC Rocky Mountain Section Annual Meeting, Apr26-27, 2015, Calgary, Alberta, Canada.

Lyon AW. Creatinine: The many faces of creatinine, an old friend I thought I knew. Muljibahai Patel Urological Hospital, Nadiad, GJ, Inida. Dec. 6th, 2014.

Jacobs E, Lyon AW. How should the IFCC Website Develop? IFCC General Conference 2012, Kuala Lumpur, Malysia. Nov 19th, 2012.

Lyon AW. Laboratory evaluation of the poisoned patient. 25th Aniverary of the Poison and Drug Information Service, Calgary. University of Calgary, Nov 5th, 2011.

Lyon AW. A brief history of analbuminemia. Special IFCC CPD symposia, Hospital for Sick Children, Toronto. Sept 2011.

Lyon AW. Webinairs, streaming media, blogs and other e-communications & clinical laboratories. IFCC – WorldLab – EuroMedLab Berlin 2011, 15-19 May 2011. Clin Chem Lab Med 2011; 49, Special Suppl, p S26.

Lyon AW. Are Glucose Meters Accurate and Precise Enough to Meet Clinical Needs?[ CSCC National Teleconference - Roundtable, Dec. 10, 2010].

Lyon AW. Webinars, Streaming Media, Blogs and Other e-communications: Beyond Email. IFCC Symposia on Distance Learning. 12th Asian-Pacific Congress on Clinical Biochemistry, Seoul, Korea. Kor. J. Lab Med 2010; 30 suppl 2: S295.

Fariba Aghahafari, James A Dickinson, Rajeswari Aghoram, Andrew W Lyon. Should we measure vitamin D on all our patients? Family Medicine Forum 2009, Calgary AB, Oct 30th, 2009. College of Family Physicians of Canada.

Lyon AW, Life without Albumin: A brief history of analbuminemia.Univ. Utah, Dept. Pathology and Laboratory Medicine, Aug 31, 2009.

Lyon AW, Life Without Albumin, Swedish Society of Clinical Chemists, Grand Hotel Boras, Boras, Sweden, May 2007

Lyon AW, Pasieka J, The Paradigm Shift in Parathyroid Surgery, The Banff Pathology Course (Univ. Alberta, Univ. Calgary), Rimrock Resort Hotel, Banff, Sep 2006

Lyon AW Serum Tumor Markers: Past, Present and Future. Chemistry CE Lecture, CHR Hospitals and DSC Nov 2004

Lyon AW Serum Tumor Markers: Past, Present and Future. Department of Pathology and Laboratory Medicine Rounds. CHR Hospitals Oct 2004

Lyon AW A Prairie Encounter with Analbuminemia. Alberta College of Medical Laboratory Technologists, Jasper AB. Sept 2004

Lyon AW A Review of Recent International Guidelines on Reporting Monoclonal Gammopathies. Somagen Diagnostics Inc. Jasper, AB Sept 2004

Lyon AW Use of the Internet for Pathology and Laboratory Medicine: An update. Alberta College of Medical Laboratory Technologists. Jasper, AB Sept 2004

Lyon AW A Prairie Encounter with Analbuminemia. MDS Laboratories Medical Scientific teleconference, Canada – USA. May 2004

Lyon AW Case Studies of Abnormal Protein Electrophoresis Patterns. Workshop contributor. Somagen Diagnostics Inc. Calgary, Alberta. Oct. 2003

Lyon AW Sodium: The Spice of Life. Alberta Ortho Clinical Diagnostics Users Group. Canmore, Alberta Sept. 2003

Lyon AW The Pathophysiology of Jaundice. Alberta Society of Medical Laboratory Technologists. Annual Meeting. Canmore, Alberta. Sept. 2003

Lyon AW, Lyon ME. Does Diagnostic Blood Loss Contribute to the Risk of Transfusion in Adult Critical Care Patients? Critical Care Advisory Board – Ortho Biotech, Calgary AB Nov14, 2002

Scott R, Lyon AW. Lab Medicine and Pathology Online in 2002 – A Hands-On Interactive Tour. Canadian Laboratory Medicine Congress, May 21, 2002

Lyon AW. 1998. Neuropsychiatric Research Unit. Department of Psychiatry. College of Medicine, University of Saskatchewan.

Yatscoff R, Lyon AW, McQueen M. 1997.Forum on Laboratory Utilization Professional Affairs Division. Annual Meeting of the Canadian Society of Clinical Chemists. Halifax, NS.

Lyon AW. 1995, 1996. Department of Biochemistry, University of Saskatchewan.

Lyon AW. 1995, 1996. College of Pharmacy and Nutrition. University of Saskatchewan.

Lyon AW. 1995. Measurement of ZDV triphosphate by an HPLC/bioluminescence assay, at: Measuring zidovudine phosphorylation in patients: Methods and clinical relevance. May 19-21. Cincinnati, OH.

Lyon AW. 1995. Zidovudine triphosphate measurement with an HPLC/Bioluminescence method. Intracellular Nucleoside Workshop. AIDS Clinical Trial Group (Core pharmacology) Meeting. June 25-27. Stanford University. Palo Alto, CA.

Lyon AW. 1995. Effects of thrombin inhibitors on laboratory tests. Saskatchewan Society of Clinical Chemists. Spring Meeting. May 26. Regina, SK.